Patents by Inventor Cheol-Hyoung Park

Cheol-Hyoung Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Silk peptide for improving neuroprotective and neurofunctional effects and a method of its preparation
    Patent number: 10010574
    Abstract: A silk peptide having neuroprotective and neurofunctional activities and its preparation method are discussed. One method relates to preparing silk protein preferably having neuroprotective activity with weight average molecular weight of 200-100,000 by hydrolysis of silk fibroin; also discussed are a composition for preventing or treating brain disease comprising silk peptide and pharmaceutically acceptable carrier, and a composition for improving brain function.
    Type: Grant
    Filed: July 31, 2004
    Date of Patent: July 3, 2018
    Assignee: BRAINGUARD CO., LTD.
    Inventors: Sung Su Kim, Cheol Hyoung Park, Sang-Hyung Lee, Wan-Seok Joo, Won Bok Lee
  • Pharmaceutical composition for inhibiting apoptosis of neuron or neurodegeneration
    Patent number: 9290464
    Abstract: Provided is a pharmaceutical composition for inhibiting apoptosis of neurons or neurodegeneration. The pharmaceutical composition effectively prevents or treats diseases related to apoptosis of neurons or neurodegeneration.
    Type: Grant
    Filed: July 22, 2014
    Date of Patent: March 22, 2016
    Assignee: SK BIOPHARMACEUTICALS CO., LTD.
    Inventors: Cheol Hyoung Park, Hye Kyung Min, In Suk Park, Mi Jung Lim, Ji Won Lee, Jin Yong Chung, Yeo Jin Yoon, Joo Young Park
  • PHARMACEUTICAL COMPOSITION FOR INHIBITING APOPTOSIS OF NEURON OR NEURODEGENERATION
    Publication number: 20140350062
    Abstract: Provided is a pharmaceutical composition for inhibiting apoptosis of neurons or neurodegeneration. The pharmaceutical composition effectively prevents or treats diseases related to apoptosis of neurons or neurodegeneration.
    Type: Application
    Filed: July 22, 2014
    Publication date: November 27, 2014
    Inventors: Cheol Hyoung PARK, Hye Kyung MIN, In Suk PARK, Mi Jung LIM, Ji Won LEE, Jin Yong CHUNG, Yeo Jin YOON, Joo Young PARK
  • Pharmaceutical composition for inhibiting apoptosis of neuron or neurodegeneration
    Patent number: 8841335
    Abstract: Provided is a pharmaceutical composition for inhibiting apoptosis of neurons or neurodegeneration. The pharmaceutical composition effectively prevents or treats diseases related to apoptosis of neurons or neurodegeneration.
    Type: Grant
    Filed: May 3, 2011
    Date of Patent: September 23, 2014
    Assignee: SK Biopharmaceuticals Co., Ltd.
    Inventors: Cheol Hyoung Park, Hye Kyung Min, In Suk Park, Mi Jung Lim, Ji Won Lee, Jin Yong Chung, Yeo Jin Yoon, Joo Young Park
  • Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating Parkinson's disease using the same
    Patent number: 8828992
    Abstract: Provided are a substituted azole derivative and pharmaceutically acceptable salts thereof, a pharmaceutical composition including an effective amount of the derivative, and a method for treating Parkinson's disease in a mammal including administering an effective amount of the compound to the mammal. The azole derivative of the following Formula (I) and pharmaceutically useful salts thereof have an efficacy against Parkinson's disease from inhibitory effects of the activity of MAO-B.
    Type: Grant
    Filed: February 25, 2010
    Date of Patent: September 9, 2014
    Assignee: SK Biopharmaceuticals Co., Ltd.
    Inventors: Cheol-Hyoung Park, Hye-Kyung Min, Mi-Jung Lim, Ji-Won Lee, Jin-Yong Chung, Choon-Ho Ryu, Yeo-Jin Yoon, Mi-Kyung Ji, Joo-Young Park
  • PHARMACEUTICAL COMPOSITION FOR INHIBITING APOPTOSIS OF NEURON OR NEURODEGENERATION
    Publication number: 20130046001
    Abstract: Provided is a pharmaceutical composition for inhibiting apoptosis of neurons or neurodegeneration. The pharmaceutical composition effectively prevents or treats diseases related to apoptosis of neurons or neurodegeneration.
    Type: Application
    Filed: May 3, 2011
    Publication date: February 21, 2013
    Applicant: SK BIOPHARMACEUTICALS CO., LTD.
    Inventors: Cheol Hyoung Park, Hye Kyung Min, In Suk Park, Mi Jung Lim, Ji Won Lee, Jin Yong Chung, Yeo Jin Yoon, Joo Young Park
  • SUBSTITUTED AZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVES, AND METHOD FOR TREATING PARKINSON'S DISEASE USING THE SAME
    Publication number: 20110301150
    Abstract: Provided are a substituted azole derivative and pharmaceutically acceptable salts thereof, a pharmaceutical composition including an effective amount of the derivative, and a method for treating Parkinson's disease in a mammal including administering an effective amount of the compound to the mammal. The azole derivative of the following Formula (I) and pharmaceutically useful salts thereof have an efficacy against Parkinson's disease from inhibitory effects of the activity of MAO-B.
    Type: Application
    Filed: February 25, 2010
    Publication date: December 8, 2011
    Inventors: Cheol-Hyoung Park, Hye-Kyung Min, Mi-Jung Lim, Ji-Won Lee, Jin-Yong Chung, Choon-Ho Ryu, Yeo-Jin Yoon, Mi-Kyung Ji, Joo-Young Park
  • Silk Peptide For Improving Neuroprotective And Neurofunctional Effects And A Method Of Its Prepartion
    Publication number: 20110105402
    Abstract: A silk peptide having neuroprotective and neurofunctional activities and its preparation method are discussed. One method relates to preparing silk protein preferably having neuroprotective activity with weight average molecular weight of 200-100,000 by hydrolysis of silk fibroin; also discussed are a composition for preventing or treating brain disease comprising silk peptide and pharmaceutically acceptable carrier, and a composition for improving brain function.
    Type: Application
    Filed: July 31, 2004
    Publication date: May 5, 2011
    Applicant: BRAINGUARD CO., LTD.
    Inventors: Sung Su Kim, Yong Koo Kang, Cheol Hyoung Park, Sang-Hyung Lee, Wan-Seok Joo, Won Bok Lee, Hee Sun Chae, Hye Kyung Na
  • Composition comprising minocycline as an effective component for prevention and treatment of dementia, and learning and memory impairments
    Publication number: 20060148766
    Abstract: The present invention relates to a composition for preventing and treating dementia and memory impairment, which contains minocycline as active ingredient. The composition of the present invention has an effect of inhibiting brain cell death and memory impairment, which are induced by amyloid beta-protein and C-terminal protein. Thus, the composition of the present invention is useful for the prevention and treatment of various dementias, including Alzheimer's disease, and the impairment of learning and memory and cognitive function.
    Type: Application
    Filed: March 13, 2006
    Publication date: July 6, 2006
    Inventors: Yoo-Hun Suh, Hye-Sun Kim, Cheol-Hyoung Park, Eun-Mee Kim, Ki-Young Shin
  • Composition comprising minocycline as an effective component for prevention and treatment of dementia, and learning and memory impairments
    Publication number: 20040266739
    Abstract: The present invention relates to a composition for preventing and treating dementia and memory impairment, which contains minocycline as active ingredient. The composition of the present invention has an effect of inhibiting brain cell death and memory impairment, which are induced by amyloid beta-protein and C-terminal protein. Thus, the composition of the present invention is useful for the prevention and treatment of various dementias, including Alzheimer's disease, and the impairment of learning and memory and cognitive function.
    Type: Application
    Filed: September 9, 2003
    Publication date: December 30, 2004
    Inventors: Yoo-Hun Suh, Hye-Sun Kim, Cheol-Hyoung Park, Eun-Mee Kim, Ki-Young Shin
  • Memory enhancing and anti-dementia agent containing dehydroevodiamine HC1 as active ingredient
    Patent number: 5859016
    Abstract: Dehydroevodiamine-HCl, a constituent of Evodia rutaecarpa Benth. (DHED) exhibits anti-AChE activity and improves the memory impairment of animals produced by scopolamine in the passive avoidance test. Thus, DHED can be a potent, long term memory enhancing and anti-dementia agent if it is used together with a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: March 12, 1997
    Date of Patent: January 12, 1999
    Assignees: JE IL Pharmaceutical Co., Ltd., Yoo-Hun Suh
    Inventors: Yoo-Hun Suh, Sam-Sik Kang, Seong-Hun Kim, Cheol-Hyoung Park, Woong Choi